Arcutis Biotherapeutics: Soaring On Q3 Earnings - Further Upside Likely (Upgrade) (ARQT)

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?The stock of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT ) is buoyant in trading today—up 30%, to a price of $26—its highest value since August 2022—after the company released its Q3 earnings .The group is for both ...